InvestorsHub Logo
Followers 21
Posts 818
Boards Moderated 0
Alias Born 04/10/2005

Re: None

Friday, 10/05/2012 12:43:00 PM

Friday, October 05, 2012 12:43:00 PM

Post# of 30990
Is John Mauldin Testing a new Anatabloc Prototype???????

John Mauldin is testing a new prototype ........his new toy which he has mentioned several times.

John Mauldin October 2, 2012

I will be at the UBS conference with my partners from Altegris and will also spend an evening with my good friend Pat Cox, who writes Breakthrough Technology Alert. I am sure we will talk about the latest technologies and especially those that may help both of us fight off the ravages of growing older. Pat has the prototype of a new “toy” that he is raving about. I have been able to procure a prototype as well, and if it works even half as well as the study results out of Stanford suggest, I will let you know. Just think of me as your friendly neighborhood guinea pig.
John Mauldin October 5, 2012 nearly mentions Anatabloc
In the Intro to the "Outside the Box" Newsletter he send out today, John Mauldin wrote :

"But I will note that I did 189 push-ups today (sets of 50, 50, 50, and 39 with other upper-body exercises) at the gym. That is twice as many as I have ever done. There is a story behind that, as technology “assisted” me. I still had to do the actual work, but a prototype of a new invention (no, not available yet) allowed me to recover from my exertion much, much faster and therefore do more actual pushing and pumping in the same amount of time. Nothing magic. No cool new biotech pill that makes me 10 times stronger. And no mechanical assists. I will write more at a later time as I test my new toy, but the first day was cool. Let’s see how it works in a few months. But a great way to start another year." END

Other Comment

"It was John Mauldin who introduced me and about 1000 other attendees to Star Scientific's discovery and Anatabloc at the Agora Financial symposium 7/11. In fact when he was done describing the history and science behind it he had most of the audience drooling, ok maybe not exactly drooling but a strong desire for Anatabloc and then he popped two in his mouth. You'll note this was 2 months before the general release of Anatabloc and John was given a supply of it early. So yeah it would appear John gets early access to new technology."


"John is a renowned financial expert, a New York Times best-selling author, a pioneering online commentator, and the publisher one of the first publications to provide investors with free, unbiased information and guidance, Thoughts from the Frontline—the most widely read investment newsletter in the world. Each week, well over a million readers turn to John Mauldin to better understand Wall Street, global markets, and the drivers of the world economy. "
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.